Fusion proteins between cell-targeting domains and cytotoxic proteins should be particularly effective therapeutic reagents. We constructed a family of immunofusion proteins linking humanized Fab, F(ab`), or single chain antibody forms of the H65 antibody (which recognizes the CD5 antigen on the surface of human T cells) with the plant ribosome-inactivating protein gelonin. We reasoned that such an immunofusion would kill human target cells as efficiently as the previously described chemical conjugates of H65 and gelonin (Better M., Bernhard, S. L., Fishwild, D. M., Nolan, P. A., Bauer, R. J., Kung, A. H. C., and Carroll, S. F.(1994) J. Biol. Chem. 269, 9644-9650) if both the recognition and catalytic domains remained active, and a proper linkage between domains could be found. Immunofusion proteins were produced in Escherichia coli as secreted proteins and were recovered directly from the bacterial culture supernatant in an active form. All of the immunofusion proteins were purified by a common process and were tested for cytotoxicity toward antigen-positive human cells. A 20-60-fold range of cytotoxic activity was seen among the fusion family members, and several fusion proteins were identified which are approximately as active as effective chemical conjugates. Based on these constructs, immunofusion avidity and potency can be controlled by appropriate selection of antibody domains and ribosome-inactivating protein.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				C. J. Provoda, E. M. Stier, and K.-D. Lee Tumor Cell Killing Enabled by Listeriolysin O-liposome-mediated Delivery of the Protein Toxin Gelonin J. Biol. Chem., September 12, 2003; 278(37): 35102 - 35108. [Abstract] [Full Text] [PDF]

				P.-L. Tazzari, L. Polito, A. Bolognesi, M.-P. Pistillo, P. Capanni, G. L. Palmisano, R. M. Lemoli, A. Curti, L. Biancone, G. Camussi, et al. Immunotoxins Containing Recombinant Anti-CTLA-4 Single-Chain Fragment Variable Antibodies and Saporin: In Vitro Results and In Vivo Effects in an Acute Rejection Model J. Immunol., October 15, 2001; 167(8): 4222 - 4229. [Abstract] [Full Text] [PDF]

				F. J. Hoedemaeker, T. Signorelli, K. Johns, D. A. Kuntz, and D. R. Rose A Single Chain Fv Fragment of P-glycoprotein-specific Monoclonal Antibody C219. DESIGN, EXPRESSION, AND CRYSTAL STRUCTURE AT 2.4 A RESOLUTION J. Biol. Chem., November 21, 1997; 272(47): 29784 - 29789. [Abstract] [Full Text] [PDF]

				J. A. Francisco, S. L. Gawlak, and C. B. Siegall Construction, Expression, and Characterization of BD1-G28-5 sFv, a Single-chain Anti-CD40 Immunotoxin Containing the Ribosome-inactivating Protein Bryodin 1 J. Biol. Chem., September 26, 1997; 272(39): 24165 - 24169. [Abstract] [Full Text] [PDF]